Imaging software developer Median Technologies has appointed Thomas Bonnefont as its new chief operating and commercial officer, as well as Mike Doherty as its senior strategy advisor for product development.
The new posts follow the company's initial success with its artificial intelligence technology iBiopsy in 2020 and early 2021, it said. Bonnefont will manage the whole iBiopsy business unit starting on 1 March and will report to Median CEO and founder Fredrik Brag. Doherty will help with iBiopsy's development and regulatory process.
